Veeva Systems Inc.
VEEVHealthcareNASDAQHealth Information Services
Scan Results
Daily timeframeVeeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. With a market capitalization of $29.86B, it sits in large-cap territory. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands.
Market Cap
$29.86B
Beta
0.92
P/E (TTM)
33.69
P/E (Fwd)
18.51
EPS (TTM)
$5.43
EPS (Fwd)
$9.88
ROE
13.9%
ROA
7.2%
Cash
$6.56B
Total Debt
$95.9M
Free CF
$1.05B
52W Change
-35.5%
Annual Financials
Cash vs Debt
Veeva Systems Inc. holds $6.56B in cash against $95.9M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Annual free cash flow of $1.05B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 13.9% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 7.2% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $2.16B (2023) to $3.20B (2026), reflecting a 48% increase over the period.
With cash comfortably exceeding debt, VEEV has financial flexibility that may help navigate uncertain periods. No single metric tells the full story. Reviewing VEEV's risk profile alongside its fundamentals and technical indicators provides a more complete picture.